Hyderabad, Dec 29 :    Hyderabad, Dec 29:  The merger of Cheminor Drugs Ltd with Dr. Reddy's Laboratories was completed today, converting it into an integrated multinational pharmacuetical company. The Andhra Pradesh high court today approved the merger with effect from April 2000. PricewaterhouseCoopers had conducted the valuation of both the companies prior to the merger and suggested a swap ratio of nine shares of DRL against 25 shares of Cheminor Drugs. DRL, which acquired American Remedies Ltd (ARL) a Chennai-based company in 1999 with a turnover of Rs 943 crore, had posted a post-integration turnover of Rs 8 billion in 1999-2000. Cheminor Drugs, a DRL group company, is a leader in bulk actives, intermediaries with large export markets in the US, Europe and Japan and reported a net sales of Rs 2154 million in 1999-2000. DRL now plans an ADR issue in the middle of 2001.